Risk factors and effects on long-term outcomes of cardiac troponin i elevation after drug-eluting stent implantation in patients with stable coronary artery disease

American Journal of Cardiology

Volumn 109, Issue 4, 2012, Pages 461-465

  Koh, Jin Sin ^a,b   Park, Jae Hong ^c   Shin, Dong Ho ^d   Youn, Tae Jin ^a   Oh, Il Young ^a   Yoon, Chang Hwan ^a   Suh, Jung Won ^a   Cho, Young Seok ^a   Cho, Goo Yeong ^a   Chae, In Ho ^a   Choi, Dong Ju ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Gyeongsang National University   (South Korea)

^c Kangnam General Hospital   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; RAPAMYCIN; TROPONIN I;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROSTHESIS DESIGN; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TROPONIN I;

EID: 84856479027     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.09.039     Document Type: Article

References (19)

1. M.J. Ricciardi, C.J. Davidson, G. Gubernikoff, N. Beohar, L.J. Eckman, M.A. Parker, R.O. Bonow Troponin I elevation and cardiac events after percutaneous coronary intervention Am Heart J 145 2003 522 528 (Pubitemid 36390500)
2. T. Nageh, R.A. Sherwood, B.M. Harris, M.R. Thomas Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease Heart 91 2005 1181 1185 (Pubitemid 41192395)
3. A.T. Ong, R.T. van Domburg, J. Aoki, K. Sonnenschein, P.A. Lemos, P.W. Serruys Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry J Am Coll Cardiol 47 2006 1356 1360
4. B.L. van der Hoeven, S.S. Liem, J.W. Jukema, N. Suraphakdee, H. Putter, J. Dijkstra, D.E. Atsma, M. Bootsma, K. Zeppenfeld, P.V. Oemrawsingh, E.E. van der Wall, M.J. Schalij Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study J Am Coll Cardiol 51 2008 618 626 (Pubitemid 351186867)
5. B. Horst, C.S. Rihal, D.R. Holmes Jr, J.F. Bresnahan, A. Prasad, G. Gau, R. Lennon, A. Lerman Comparison of drug-eluting and bare-metal stents for stable coronary artery disease JACC Cardiovasc Interv 2 2009 321 328
6. A.J. Kirtane, A. Gupta, S. Iyengar, J.W. Moses, M.B. Leon, R. Applegate, B. Brodie, E. Hannan, K. Harjai, L.O. Jensen, S.J. Park, R. Perry, M. Racz, F. Saia, J.V. Tu, R. Waksman, A.J. Lansky, R. Mehran, G.W. Stone Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies Circulation 119 2009 3198 3206
7. G.W. Stone, S.G. Ellis, A. Colombo, K.D. Dawkins, E. Grube, D.E. Cutlip, M. Friedman, D.S. Baim, J. Koglin Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation Circulation 115 2007 2842 2847 (Pubitemid 46869671)
8. E. Braunwald, E.M. Antman, J.W. Beasley, R.M. Califf, M.D. Cheitlin, J.S. Hochman, R.H. Jones, D. Kereiakes, J. Kupersmith, T.N. Levin, C.J. Pepine, J.W. Schaeffer, E.E. Smith 3rd, D.E. Steward, P. Theroux, R.J. Gibbons, J.S. Alpert, K.A. Eagle, D.P. Faxon, V. Fuster, T.J. Gardner, G. Gregoratos, R.O. Russell, S.C. Smith Jr ACC/AHA guidelines for the management of patients with unstable angina and nonST-segment elevation myocardial infarction: executive summary and recommendations A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee on the management of patients with unstable angina) Circulation 102 2000 1193 1209
9. R. Mehran, G. Dangas, G.S. Mintz, A.J. Lansky, A.D. Pichard, L.F. Satler, K.M. Kent, G.W. Stone, M.B. Leon Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients Circulation 101 2000 604 610 (Pubitemid 30094730)
10. A. Prasad, J. Herrmann Myocardial infarction due to percutaneous coronary intervention N Engl J Med 364 2011 453 464
11. W.J. Cantor, L.K. Newby, R.H. Christenson, R.H. Tuttle, V. Hasselblad, P.W. Armstrong, D.J. Moliterno, R.M. Califf, E.J. Topol, E.M. Ohman SYMPHONY and 2nd SYMPHONY Cardiac Markers Substudy Investigators Prognostic significance of elevated troponin I after percutaneous coronary intervention J Am Coll Cardiol 39 2002 1738 1744 (Pubitemid 34595282)
12. S. Fuchs, R. Kornowski, R. Mehran, A.J. Lansky, L.F. Satler, A.D. Pichard, K.M. Kent, C.E. Clark, G.W. Stone, M.B. Leon Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions Am J Cardiol 85 2000 1077 1082 (Pubitemid 30214252)
13. A.S. Kini, P. Lee, J.D. Marmur, A. Agarwal, M.E. Duffy, M.C. Kim, S.K. Sharma Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality Am J Cardiol 93 2004 18 23 (Pubitemid 38022028)
14. C. Cavallini, S. Savonitto, R. Violini, G. Arraiz, M. Plebani, Z. Olivari, P. Rubartelli, S. Battaglia, L. Niccoli, G. Steffenino, D. Ardissino Italian Atherosclerosis, Thrombosis, and Vascular Biology and Society for Invasive CardiologyGISE Investigators Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study Eur Heart J 26 2005 1494 1498 (Pubitemid 41373489)
15. C. Cavallini, P. Verdecchia, S. Savonitto, G. Arraiz, R. Violini, Z. Olivari, P. Rubartelli, S. De Servi, M. Plebani, G. Steffenino, P. Sbarzaglia, D. Ardissino Italian Atherosclerosis, Thrombosis and Vascular Biology and Society for Invasive CardiologyGISE Investigators Prognostic value of isolated troponin I elevation after percutaneous coronary intervention Circ Cardiovasc Interv 3 2010 431 435
16. M.K. Natarajan, C. Kreatsoulas, J.L. Velianou, S.R. Mehta, D. Pericak, D.M. Goodhart Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions Am J Cardiol 93 2004 750 753 (Pubitemid 38338569)
17. A. De Labriolle, G. Lemesle, L. Bonello, A.I. Syed, S.D. Collins, I. Ben-Dor, T.L. Pinto Slottow, Z. Xue, R. Torguson, W.O. Suddath, L.F. Satler, K.M. Kent, A.D. Pichard, J. Lindsay, R. Waksman Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery Am J Cardiol 103 2009 639 645
18. A. Prasad, C.S. Rihal, R.J. Lennon, M. Singh, A.S. Jaffe, D.R. Holmes Jr Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients Circ Cardiovasc Interv 1 2008 10 19
19. D.N. Feldman, L. Kim, A.G. Rene, R.M. Minutello, G. Bergman, S.C. Wong Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis Catheter Cardiovasc Interv 77 2011 1020 1030